Go Pro
→ Trump and Bernie agree on this (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.90
-11.2%		$1.06
$0.82
▼
$16.68
$4.51M0.913.13 million shs319,394 shs
HeartSciences Inc. stock logo
HSCS
HeartSciences
$3.39
-3.4%		$2.67
$1.63
▼
$4.35
$13.69M1.85153,975 shs100,657 shs
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$1.56
-1.3%		$1.97
$1.42
▼
$6.96
$14.39M0.65806,876 shs64,233 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.12
-5.4%		$0.14
$0.03
▼
$1.00
$13.23M1.2674,785 shs20,213 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-11.16%+7.80%-14.54%-81.65%-84.53%
HeartSciences Inc. stock logo
HSCS
HeartSciences
-3.42%-9.12%+69.50%+88.33%+2.42%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-1.27%-3.70%+2.63%-51.85%-70.72%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
-5.38%-0.09%-12.07%-31.76%-64.52%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.90
-11.2%		$1.06
$0.82
▼
$16.68
$4.51M0.913.13 million shs319,394 shs
HeartSciences Inc. stock logo
HSCS
HeartSciences
$3.39
-3.4%		$2.67
$1.63
▼
$4.35
$13.69M1.85153,975 shs100,657 shs
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$1.56
-1.3%		$1.97
$1.42
▼
$6.96
$14.39M0.65806,876 shs64,233 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.12
-5.4%		$0.14
$0.03
▼
$1.00
$13.23M1.2674,785 shs20,213 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-11.16%+7.80%-14.54%-81.65%-84.53%
HeartSciences Inc. stock logo
HSCS
HeartSciences
-3.42%-9.12%+69.50%+88.33%+2.42%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-1.27%-3.70%+2.63%-51.85%-70.72%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
-5.38%-0.09%-12.07%-31.76%-64.52%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
1.00
SellN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
2.00
Hold$8.00135.99% Upside
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
2.40
Hold$7.33370.09% Upside
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BJDX, HSCS, TMDIF, and NMTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2026
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/14/2026
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
Maxim Group logo
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$13.00 ➝ $5.00
7/28/2026
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/24/2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/24/2026
HeartSciences Inc. stock logo
HSCS
HeartSciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/A$8.43 per shareN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/A$0.07 per shareN/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$12.10M1.17N/AN/A$0.85 per share1.84
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$17.63M0.75$5.80 per share0.02$1.05 per share0.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$6.85M-$7.11N/AN/AN/AN/A-125.00%-99.79%11/13/2026 (Estimated)
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$9.14M-$3.94N/AN/AN/AN/A-358.60%-144.82%N/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$3.61M-$0.95N/AN/AN/A-71.50%-128.12%-86.34%N/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$6.95M$0.05N/AN/AN/AN/A-82.31%-51.47%N/A

Latest BJDX, HSCS, TMDIF, and NMTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q3 2026
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$0.21-$0.28-$0.07-$0.28$2.17 million$1.97 million
8/12/2026Q2 2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$3,520.00-$1.12+$3,518.88-$1.12N/AN/A
7/23/2026Q4 2026
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$0.66-$0.88-$0.22-$0.87$0.05 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/AN/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
4.64
4.64
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/A
0.53
0.40
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/A
2.84
1.71
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/A
3.73
3.73

Institutional Ownership

CompanyInstitutional Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
HeartSciences Inc. stock logo
HSCS
HeartSciences
17.24%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
16.07%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.03%

Insider Ownership

CompanyInsider Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
6.10%
HeartSciences Inc. stock logo
HSCS
HeartSciences
4.90%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
11.80%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.02%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
94.47 million4.20 millionNot Optionable
HeartSciences Inc. stock logo
HSCS
HeartSciences
103.90 million3.71 millionNot Optionable
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
209.11 million8.03 millionOptionable
Titan Medical Inc. stock logo
TMDIF
Titan Medical
50114.04 million4.56 millionNot Optionable

Recent News About These Companies

Titan Medical Group Launches Titan Workforce Solutions: Launches to Transform Healthcare Staffing
April 29, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250410721416/en/titan-medical-group-launches-titan-workforce-solutions-launches-to-transform-healthcare-staffing/
Titan Nurse Staffing, LLC and Titan Medical Group, LLC Announce Merger to Streamline Healthcare Staffing Services
April 29, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250410050922/en/Titan-Nurse-Staffing-LLC-and-Titan-Medical-Group-LLC-Announce-Merger-to-Streamline-Healthcare-Staffing-Services/
Titan MRI acquires High Field MRI, expanding Titan MRI's service to North Central Florida
December 3, 2024  |  msn.comhttps://www.msn.com/en-us/health/other/titan-mri-acquires-high-field-mri-expanding-titan-mri-s-service-to-north-central-florida/ar-AA1v8Qwd
Attack on Titan movie release date, trailer, changes, and everything else we know about The Last Attack
November 6, 2024  |  gamesradar.comG
Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination
October 11, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/10/11/2962201/0/en/conavi-medical-corp-formerly-titan-medical-inc-completes-business-combination.html
Titan Announces the Closing of Conavi's Private Placement of Subscription Receipts and Provides Update on the Transaction
October 8, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/10/08/2959991/0/en/titan-announces-the-closing-of-conavi-s-private-placement-of-subscription-receipts-and-provides-update-on-the-transaction.html
Titan Announces Resignations of Directors
October 2, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/10/02/2956850/0/en/titan-announces-resignations-of-directors.html
Titan Reports Voting Results from 2023 Annual General and Special Meeting
September 30, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/30/2955702/0/en/titan-reports-voting-results-from-2023-annual-general-and-special-meeting.html
Titan Medical begins process to move to the TSX Venture Exchange
September 30, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/30/2955668/0/en/titan-medical-begins-process-to-move-to-the-tsx-venture-exchange.html
Conavi Medical Shareholders Approve the Proposed Amalgamation Between Titan and Conavi
September 26, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/26/2954026/0/en/conavi-medical-shareholders-approve-the-proposed-amalgamation-between-titan-and-conavi.html
Proxy Deadline Thursday September 26, 2024
September 25, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/25/2952858/0/en/proxy-deadline-thursday-september-26-2024.html
Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
September 19, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/19/2949214/0/en/proxy-advisor-glass-lewis-co-recommends-titan-shareholders-vote-for-the-amalgamation-between-titan-and-conavi.html
A key employee says the Titan sub tragedy could have been prevented
September 18, 2024  |  postregister.comP
Titan Announces Conavi Medical to Present Overview at Titan Q&A Session
September 16, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/16/2947052/0/en/titan-announces-conavi-medical-to-present-overview-at-titan-q-a-session.html
Independent Proxy Advisor, Institutional Shareholder Services (“ISS”), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi
September 16, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/16/2947053/0/en/independent-proxy-advisor-institutional-shareholder-services-iss-recommends-titan-shareholders-vote-for-the-amalgamation-between-titan-and-conavi.html
Titan Announces Q&A Session with Shareholders
September 9, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/09/2942725/0/en/titan-announces-q-a-session-with-shareholders.html
Titan Announces Filing of the Management Information Circular.
September 6, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/09/06/2942138/0/en/titan-announces-filing-of-the-management-information-circular.html
Titan Medical | Morning Blend
September 3, 2024  |  msn.comhttps://www.msn.com/en-us/video/other/titan-medical-morning-blend/vi-AA1pUDwV
Titan Medical Inc. (QTNA.SG)
August 24, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/QTNA.SG/news/
Titan Medical Reports Operating and Financial Results for the Second Quarter 2024
August 15, 2024  |  globenewswire.comhttps://www.globenewswire.com/news-release/2024/08/15/2931147/0/en/titan-medical-reports-operating-and-financial-results-for-the-second-quarter-2024.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$0.90 -0.11 (-11.16%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$0.86 -0.04 (-4.71%)
As of 09/11/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

HeartSciences stock logo

HeartSciences NASDAQ:HSCS

$3.39 -0.12 (-3.42%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.50 +0.11 (+3.22%)
As of 09/11/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

NeuroOne Medical Technologies stock logo

NeuroOne Medical Technologies NASDAQ:NMTC

$1.56 -0.02 (-1.27%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$1.56 -0.01 (-0.32%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Titan Medical stock logo

Titan Medical NASDAQ:TMDIF

$0.12 -0.01 (-5.38%)
As of 09/10/2026

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas